Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · August 30, 2012

Adjuvant 5-FU Plus Oxaliplatin in Colon Cancer Subsets Yields No Benefit

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (Between Ages 70 and 75 Years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
J. Clin. Oncol 2012 Aug 20;[EPub Ahead of Print], C Tournigand, T Andre, F Bonnetain, B Chibaudel, G Lledo, T Hickish, J Tabernero, C Boni, J-B Bachet, L Teixeira, A de Gramont

Further Reading